ascopubs.org

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations

NF1-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of NF1-Mutant Rhabdomyosarcoma and NF1-Associated Malignant Triton Tumor The Prostate Cancer Precision Medicine Multi ...
Medical Xpress

RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment

Different genomic alterations in DNA damage repair (DDR) pathways occur in 20% to 25% of advanced prostate cancer, including homologous recombination repair (HRR) gene alterations. Identifying the ...
Nature

Clinical implementation of next-generation sequencing testing and genomically-matched therapy: a real-world data in a tertiary hospital

The last decade has seen a significant shift in how patients with cancer are diagnosed and managed through the clinical application of next-generation sequencing (NGS) technology. Large-scale tumor ...
Labroots

Beyond the noise: Identifying clinically relevant mutations in somatic NGS testing

Next-generation sequencing (NGS) allows the simultaneous analysis of multiple genomic alterations with therapeutic implications, paving the way for precision medicine and transforming cancer care.
Labroots

Break the ceiling: Elevate your oncology NGS testing with expert-curated data

When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along with the ...